Henry Schein Inc.(0L3C)
USD --+0.00%
Reward43Moderate
Risk53Moderate
📊75%Data
Thin 3% profit margin
0L3C
+0.0 · +0.00%
USD · LSE
Henry Schein Inc. |
Speculative Momentum
Market Cap:
ℹ️
Reward Rating
43
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
53
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on 0L3C to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Henry Schein Inc.?

provides health care products and services to office-based dental and medical practitioners worldwide.

0L3C · Verdict

Moderate reward · elevated risk

0L3C has limited near-term tailwinds — profitability and balance sheet weigh on the model output.

Based on 88% data coverage

0L3C · Verdict

What’s working & what to watch

Watchouts 4

  • Profitability37/100

    3% net margin · 9% ROE

  • Balance sheet39/100

    Interest covered 4.6×

  • Growth43/100

    Rev +2.2% CAGR · earnings -1.5%

  • Valuation43/100

    Below average

Model-based scoring. For information only — not financial advice.

What is Henry Schein Inc.?

provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company is listed on the LSE in UK, and a P/E ratio of 0.2x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Discount reflects uncertainty around future performance.

OpenBook Logo Analysis

Reward: Moderate (43)

The scoring profile indicates limited reward potential at this time, with momentum and size offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorN/A
Market CapN/A
P/E Ratio0.1619
Dividend YieldN/A
52 Week High88.45
52 Week Low62.29
Last AnnualDecember
IPO DateN/A
IncorporatedUK
Shares Outstanding157M
No. of Employees25,000
IndustryN/A
ExchangeLSE
Beta0.882
CurrencyUSD